市场调查报告书
商品编码
1464787
心电图远端检测设备市场:按设备、应用和最终用户划分 - 全球预测 2024-2030ECG Telemetry Devices Market by Device (Event Monitors, Holter Monitors, Implantable Loop Recorders), Application (Arrhythmia Detection & Monitoring, Heart Rate Variability Analysis, Ischemia Detection), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年心远端检测设备市场规模为53.9亿美元,预计2024年将达57.4亿美元,2030年将达86亿美元,复合年增长率为6.88%。
心电图远端检测设备是一种先进的医疗设备,旨在连续监测、记录和无线传输患者的心电图 (ECG)资料。这些设备对于即时观察心臟活动至关重要,使医疗保健专业人员能够快速识别和应对潜在危及生命的疾病,例如心律不整、心臟病和其他心肺问题。心电图遥测技术的使用极大地提高了患者的活动能力,并且无需物理靠近监测设备,从而创造了更舒适、更有效率的患者照护环境。全球心血管疾病盛行率不断上升,需要高效、即时的监测系统,增加了对心电图远端检测设备的需求。人口老化更容易患慢性心臟病,进一步增加了对心电图远端检测设备的需求。儘管采用率不断提高,但与新设备核准流程相关的严格监管政策正在阻碍市场成长。然而,人工智慧和机器学习演算法的整合彻底改变了心电图远端检测设备的预测能力并提高了其效率和准确性,为市场参与者提供了新的成长途径。
主要市场统计 | |
---|---|
基准年[2023] | 53.9亿美元 |
预测年份 [2024] | 57.4亿美元 |
预测年份 [2030] | 86亿美元 |
复合年增长率(%) | 6.88% |
心臟事件记录器用于记录一段时间内的心电活动,通常在患者出现头晕、心悸或胸痛等症状时开始记录。这些携带式设备专为短期监测而设计,通常规定使用几天到几週。心电图监测是一种小型穿戴式设备,可连续记录 24 小时内的心臟电活动。心电图监测记录监测期间的每次心率,让您全面了解一段时间内的心臟活动。这种持续监测对于检测心律不整、监测心臟药物的有效性以及评估心臟病发作后的恢復情况至关重要。植入式动态心电图监测仪(ILR) 是一种小型心臟监测设备,透过手术放置在胸部皮下,可持续监测心律长达三年。它可以让您长时间监测您的心律,对于经常出现不明原因昏厥或心悸的患者特别有用。行动心电遥测(MCT) 设备是先进的即时心臟监测系统,专为连续心电图监控和向医疗保健提供者即时资料传输而设计。这些设备对于诊断和治疗需要持续监测的复杂心律不整患者特别有用。 MCT 设备一旦侦测到异常心律,就会立即通知医疗保健提供者,以便快速做出反应和调整治疗。移动和无线功能可确保患者的舒适度和活动自由度,有助于提高患者的依从性,并随着时间的推移更准确地评估心臟健康状况。
应用 扩大心电图远端检测设备在远端患者监护的使用
心律不整检测和监测是心电远端检测设备的重要应用之一。这些先进的设备旨在连续记录心臟的电活动,使它们能够即时识别心律不整和心律不整。这项功能对于早期诊断和及时干预、降低中风和心臟衰竭等併发症的风险至关重要。心电图远端检测设备提供的心率变异性 (HRV) 分析可提供对自主神经系统功能和心臟健康的有意义的了解。心率变异性是指心率之间时间间隔的变化,是压力、健身程度和整体心臟健康的替代。分析 HRV 可以帮助您发现心臟病的早期征兆、管理压力并提高运动表现。缺血检测是心电远端检测设备的重要应用,重点在于辨识心肌血流量减少。如果不及时发现,这种情况可能会导致严重的心臟疾病。心电图远端检测设备监测和分析心臟的电模式并识别显示缺血的变化。远端患者监护(RPM) 是心电图远端检测设备的创新应用,有助于在传统临床环境之外追踪病患的心臟健康状况。这种方法透过持续即时监测关键心臟参数,增加患者接受治疗的机会,改善健康结果,并降低医疗成本。 ST 段监测是心臟电远端检测设备的基本功能,旨在以高特异性和敏感性检测心肌缺血和梗塞。 ST 段代表心臟电週期的关键阶段,偏离正常模式可能表示重大心臟事件。持续监测ST段可以及早发现此类事件,有利于及时的临床介入。
区域洞察
在美洲,心血管疾病的日益普及和人口老化正在推动对心电图远端检测设备的需求。由于其先进的医疗基础设施、高额医疗支出以及主要心电图远端检测设备製造商的强大影响力,美国对该区域市场做出了重大贡献。欧洲地区由于其先进的医疗保健系统和有利的医疗设备法规环境而大量采用心电图远端检测设备。由于医疗成本上升和对心血管疾病的认识提高,中东和非洲地区也正在推动采用。在人口快速成长、文明病盛行率上升、医疗成本上升以及医疗保健意识不断增强的推动下,亚太地区心电图远端检测设备已快速普及。该地区的市场也受益于医疗基础设施的改善和创新技术的采用增加。
FPNV定位矩阵
FPNV定位矩阵对于评估ECG远端检测设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对心电图远端检测设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.心电远端检测设备市场的市场规模与预测是多少?
2.心电图远端检测设备市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.心电远端检测设备市场的技术趋势和法规结构是什么?
4.心电远端检测设备市场主要厂商的市场占有率是多少?
5. 进入心电远端检测设备市场的适当型态和策略手段是什么?
[189 Pages Report] The ECG Telemetry Devices Market size was estimated at USD 5.39 billion in 2023 and expected to reach USD 5.74 billion in 2024, at a CAGR 6.88% to reach USD 8.60 billion by 2030.
ECG telemetry devices are advanced medical tools designed for the continuous monitoring, recording, and wireless transmission of patients' electrocardiogram (ECG) data. These devices are pivotal in the real-time observation of cardiac activities, enabling healthcare professionals to swiftly detect and respond to any irregularities or potentially life-threatening conditions such as arrhythmias, heart attacks, and other cardiopulmonary issues. Through the utilization of ECG telemetry, patient mobility is significantly improved, as the necessity for immediate physical proximity to monitoring equipment is eliminated, facilitating a more comfortable and efficient patient care environment. The increasing prevalence of cardiovascular diseases globally necessitates efficient and real-time monitoring systems, fostering the need for ECG telemetry devices. The aging population, highly susceptible to chronic heart conditions, further boosts the need for ECG telemetry devices. Despite the growing adoption, stringent regulatory policies associated with the approval process of new devices hinder market growth. However, the integration of artificial intelligence and machine learning algorithms that could revolutionize the predictive capabilities of ECG telemetry devices, enhancing their efficiency and accuracy, provide new growth avenues for market players.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.39 billion |
Estimated Year [2024] | USD 5.74 billion |
Forecast Year [2030] | USD 8.60 billion |
CAGR (%) | 6.88% |
Event monitors are used to record the heart's electrical activity over a period, typically initiated by the patient when they experience symptoms such as dizziness, palpitations, or chest pain. These portable devices are designed for short-term monitoring, often prescribed for use from a few days to a few weeks. Holter monitors are compact, wearable devices that continuously record the heart's electrical activity for 24 hours or more. Holter monitors record all heartbeats during the monitoring period, providing a comprehensive view of the heart's activity over time. This continuous monitoring is crucial for detecting irregular heartbeats, monitoring the efficacy of heart medications, and assessing recovery after a heart attack. Implantable loop recorders (ILRs) are small, heart-monitoring devices that are surgically placed under the chest skin to continuously monitor the heart's rhythms for up to three years. They are particularly useful for patients with infrequent, unexplained fainting episodes or palpitations, as they allow for long-term heart rhythm monitoring. Mobile cardiac telemetry (MCT) devices are advanced, real-time heart monitoring systems designed for continuous ECG monitoring and instant data transmission to healthcare providers. These devices are particularly effective in diagnosing and managing patients with complex arrhythmias that require constant monitoring. MCT devices offer the advantage of immediate notification to healthcare providers upon detection of abnormal heart rhythms, enabling prompt response and treatment adjustments. Their mobile and wireless capabilities ensure patient comfort and freedom of movement, contributing to higher patient compliance and more accurate heart health assessments over time.
Application: Growing applications of ECG telemetry devices in remote patient monitoring
Arrhythmia detection and monitoring is one of the pivotal applications of ECG telemetry devices. These sophisticated devices are engineered to continuously record the heart's electrical activity, thereby enabling the identification of irregular heartbeats or arrhythmias in real time. This capability is critical for early diagnosis and timely intervention, reducing the risk of complications such as stroke or heart failure. Heart rate variability (HRV) analysis offered by ECG telemetry devices provides meaningful insights into the autonomic nervous system's functioning and the heart's health. Heart rate variability refers to the variation in the time interval between heartbeats and is a proxy for stress, fitness levels, and overall cardiac health. Analyzing HRV can aid in detecting early signs of heart disease, stress management, and improving athletic performance. Ischemia detection is a crucial application of ECG telemetry devices, focusing on the identification of reduced blood flow to the heart muscle. This condition, if left undetected, can lead to severe cardiac events. ECG telemetry devices monitor and analyze the heart's electrical patterns, identifying alterations that suggest the presence of ischemia. Remote patient monitoring (RPM) represents a transformative application of ECG telemetry devices, facilitating the tracking of patients' cardiac health outside traditional clinical settings. This approach enhances patient access to care, improves health outcomes, and reduces healthcare costs by enabling continuous monitoring of vital cardiac parameters in real time. ST segment monitoring is an essential function of ECG telemetry devices aimed at detecting myocardial ischemia and infarction with high specificity and sensitivity. The ST segment represents a crucial phase in the heart's electrical cycle, and deviations from its normal pattern can be indicative of significant cardiac events. Continuous ST segment monitoring allows for the early detection of such events, facilitating timely clinical intervention.
Regional Insights
In the Americas, the increasing prevalence of cardiovascular diseases and the rising aging population drive the need for ECG telemetry devices. The United States contributes majorly to the regional market, which is attributed to its advanced healthcare infrastructure, high healthcare spending, and strong presence of major ECG telemetry device manufacturers. The European region shows a significant adoption of ECG telemetry devices, owing to its advanced healthcare systems and favorable regulatory environment for medical devices. The Middle East and Africa are also supporting this adoption, driven by increasing healthcare expenditure and awareness about cardiovascular diseases. Asia-Pacific is showcasing the rapid adoption of ECG telemetry devices supported by the burgeoning population, rising prevalence of lifestyle diseases, increasing healthcare expenditure, and growing healthcare awareness. The region's market is also benefiting from improvements in healthcare infrastructure and the rising adoption of innovative technologies.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the ECG Telemetry Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ECG Telemetry Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the ECG Telemetry Devices Market, highlighting leading vendors and their innovative profiles. These include ACS Diagnostics, Inc., Aerotel Ltd., AliveCor, Inc., Biotricity, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, CompuMed, Inc., Cortrium ApS, First Call Medical Inc., GE HealthCare Technologies, Inc., Hill-Rom Services Inc. by Baxter International Inc., iRhythm Technologies Inc., Koninklijke Philips N.V., Medtronic PLC, Movesense Ltd., Nihon Kohden Corporation, Norav Medical, Qardio, Inc., ReactDx, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Telerhythmics, LLC, The ScottCare Corporation, and Zoll Medical Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the ECG Telemetry Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the ECG Telemetry Devices Market?
3. What are the technology trends and regulatory frameworks in the ECG Telemetry Devices Market?
4. What is the market share of the leading vendors in the ECG Telemetry Devices Market?
5. Which modes and strategic moves are suitable for entering the ECG Telemetry Devices Market?